Diferencia entre revisiones de «Nonsteroidal anti-inflammatory drugs»
(Text replacement - "Category:Drugs" to "Category:Pharmacology") |
(Text replacement - "* " to "*") |
||
| Línea 5: | Línea 5: | ||
===Salicylates=== | ===Salicylates=== | ||
* [[Aspirin]] ([[acetylsalicylic acid]]) | *[[Aspirin]] ([[acetylsalicylic acid]]) | ||
* [[Salicylic acid]] and other [[salicylate]]s | *[[Salicylic acid]] and other [[salicylate]]s | ||
===Propionic acid derivatives=== | ===Propionic acid derivatives=== | ||
* [[Ibuprofen]] | *[[Ibuprofen]] | ||
* [[Naproxen]] | *[[Naproxen]] | ||
* [[Ketoprofen]] | *[[Ketoprofen]] | ||
===Acetic acid derivatives=== | ===Acetic acid derivatives=== | ||
* [[Indomethacin]] | *[[Indomethacin]] | ||
* [[Ketorolac]] | *[[Ketorolac]] | ||
* [[Diclofenac]] | *[[Diclofenac]] | ||
===Selective COX-2 inhibitors (Coxibs)=== | ===Selective COX-2 inhibitors (Coxibs)=== | ||
* [[Celecoxib]] (FDA alert<ref>Information for Healthcare Professionals: Celecoxib (marketed as Celebrex) http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm124655.htm</ref>) | *[[Celecoxib]] (FDA alert<ref>Information for Healthcare Professionals: Celecoxib (marketed as Celebrex) http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm124655.htm</ref>) | ||
==See Also== | ==See Also== | ||
Revisión del 23:22 9 jul 2016
Background
- Abbreviation: NSAIDs
Types
Salicylates
- Aspirin (acetylsalicylic acid)
- Salicylic acid and other salicylates
Propionic acid derivatives
Acetic acid derivatives
Selective COX-2 inhibitors (Coxibs)
See Also
References
- ↑ Information for Healthcare Professionals: Celecoxib (marketed as Celebrex) http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm124655.htm